DUBLIN--(BUSINESS WIRE)-- <\/p>\n
Research and Markets (http:\/\/www.researchandmarkets.com\/research\/nnxfrm\/gene_therapy_drug<\/a>) has announced the addition of the \"Gene Therapy Drug Pipeline Analysis\" report to their offering. <\/p>\n Gene Therapy Drug Pipeline Analysis gives a comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. <\/p>\n Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. <\/p>\n Insight for each drug profile in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases. <\/p>\n This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Gene Therapy based drug development process. <\/p>\n Following parameters for each drug profile in development phase are covered in Gene Therapy Drug Pipeline Analysis research report: <\/p>\n - Drug Profile Overview <\/p>\n - Alternate Names for Drug <\/p>\n - Active Indication <\/p>\n <\/p>\n Read the original: <\/p>\n Research and Markets: Gene Therapy Drug Pipeline Analysis Report 2013<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" DUBLIN--(BUSINESS WIRE)-- Research and Markets (http:\/\/www.researchandmarkets.com\/research\/nnxfrm\/gene_therapy_drug<\/a>) has announced the addition of the \"Gene Therapy Drug Pipeline Analysis\" report to their offering. Gene Therapy Drug Pipeline Analysis gives a comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Continue reading